
riociguat oral brand names and other generic formulations include:
Adempas Oral
cilostazol oral brand names and other generic formulations include:
riociguat oral and cilostazol oral
riociguat oral , cilostazol oral . Either increases toxicity of the other by blood pressure lowering effect that may lead to fainting. Riociguat should not be taken with specific PDE-5 inhibitors (eg sildenafil, tadalafil, vardenafil) and nonspecific PDE-5 inhibitors (eg theophylline, dipyridamole) due to risk of low blood pressure (hypotension); data are limited with other PDE inhibitors (eg, milrinone, cilostazol, roflumilast).
riociguat oral and cilostazol oral
riociguat oral , cilostazol oral . Either increases toxicity of the other by additive vasodilation. Riociguat is contraindicated with specific PDE-5 inhibitors (eg sildenafil, tadalafil, vardenafil) and nonspecific PDE-5 inhibitors (eg theophylline, dipyridamole) due to risk of hypotension; data are limited with other PDE inhibitors (eg, milrinone, cilostazol, roflumilast)
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant